Re: Paul L. Crispen, Michael L. Blute. Do Percutaneous Renal Tumor Biopsies at Initial Presentation Affect Treatment Strategies? Eur Urol 2009;55:307-9

Byung Kwan Park

doi:10.1016/j.eururo.2009.03.011

Re: Paul L. Crispen, Michael L. Blute. Do Percutaneous Renal Tumor Biopsies at Initial Presentation Affect Treatment Strategies? Eur Urol 2009;55:307-9

Byung Kwan Park

Department of Radiology

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e105-e106
Journal	European Urology
Volume	55
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2009.03.011
State	Published - Jun 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.eururo.2009.03.011

Cite this

@article{fb34350fd0074d75b49f6c13afea4854,

title = "Re: Paul L. Crispen, Michael L. Blute. Do Percutaneous Renal Tumor Biopsies at Initial Presentation Affect Treatment Strategies? Eur Urol 2009;55:307-9",

author = "Park, \{Byung Kwan\}",

year = "2009",

month = jun,

doi = "10.1016/j.eururo.2009.03.011",

language = "English",

volume = "55",

pages = "e105--e106",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "6",

}

TY - JOUR

T1 - Re

T2 - Paul L. Crispen, Michael L. Blute. Do Percutaneous Renal Tumor Biopsies at Initial Presentation Affect Treatment Strategies? Eur Urol 2009;55:307-9

AU - Park, Byung Kwan

PY - 2009/6

Y1 - 2009/6

UR - https://www.scopus.com/pages/publications/65049083450

U2 - 10.1016/j.eururo.2009.03.011

DO - 10.1016/j.eururo.2009.03.011

M3 - Letter

C2 - 19297078

AN - SCOPUS:65049083450

SN - 0302-2838

VL - 55

SP - e105-e106

JO - European Urology

JF - European Urology

IS - 6

ER -

Re: Paul L. Crispen, Michael L. Blute. Do Percutaneous Renal Tumor Biopsies at Initial Presentation Affect Treatment Strategies? Eur Urol 2009;55:307-9

UN SDGs

Access to Document

Other files and links

Cite this